Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.

Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.

Placenta. 1998 Mar-Apr;19(2-3):171-80.

PMID:
9548184
5.

Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.

Li M, Karakji EG, Xing R, Fryer JN, Carnegie JA, Rabbani SA, Tsang BK.

Endocrinology. 1997 Jul;138(7):2790-9.

PMID:
9202219
6.

Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.

Schnaper HW, Barnathan ES, Mazar A, Maheshwari S, Ellis S, Cortez SL, Baricos WH, Kleinman HK.

J Cell Physiol. 1995 Oct;165(1):107-18.

PMID:
7559792
7.

Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression.

Bajou K, Lewalle JM, Martinez CR, Soria C, Lu H, Noël A, Foidart JM.

Int J Cancer. 2002 Aug 10;100(5):501-6.

9.

Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.

Brodsky S, Chen J, Lee A, Akassoglou K, Norman J, Goligorsky MS.

Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1784-92.

10.

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ.

Cancer Res. 2000 Oct 15;60(20):5839-47.

11.
12.
13.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
14.

Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.

Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.

Placenta. 2000 Mar-Apr;21(2-3):184-93.

PMID:
10736241
15.

Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.

Liu JW, Wei DZ, Du CB, Zhong JJ.

Acta Pharmacol Sin. 2003 Feb;24(2):102-8.

17.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
18.
19.

Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.

Chorostowska-Wynimko J, Swiercz R, Skrzypczak-Jankun E, Selman SH, Jankun J.

Oncol Rep. 2004 Dec;12(6):1155-62.

PMID:
15547731
20.

ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.

Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, Postigo A.

Clin Cancer Res. 2013 Mar 1;19(5):1071-82. doi: 10.1158/1078-0432.CCR-12-2675. Epub 2013 Jan 22.

Supplemental Content

Support Center